Difficulty: Medium
Average Score: 79%
Practice
Although children with Wilms tumor have a favorable prognosis, there are some adverse prognostic factors in children with Wilms tumor EXCEPT
Correct answer
D
Rationale
In pediatric oncology, understanding prognostic factors in Wilms tumor is crucial for providing optimal care. In this scenario, the correct answer is D) young age at diagnosis. This is because younger age at diagnosis is actually associated with a more favorable prognosis in Wilms tumor, contrary to the other options.
Option A) large tumors are considered an adverse prognostic factor in Wilms tumor due to increased risk of metastasis and complications. Option B) anaplastic histology is associated with a poorer prognosis as it indicates a more aggressive form of the tumor. Option C) loss of heterozygosity at chromosome 1p and 16q is also a negative prognostic factor in Wilms tumor.
Educationally, it is important for nurses caring for pediatric oncology patients to be aware of these prognostic factors to assist in providing comprehensive care, educating families, and understanding the treatment implications based on these factors. Understanding these nuances helps nurses in advocating for their young patients and supporting families through the complexities of cancer treatment.
Option A) large tumors are considered an adverse prognostic factor in Wilms tumor due to increased risk of metastasis and complications. Option B) anaplastic histology is associated with a poorer prognosis as it indicates a more aggressive form of the tumor. Option C) loss of heterozygosity at chromosome 1p and 16q is also a negative prognostic factor in Wilms tumor.
Educationally, it is important for nurses caring for pediatric oncology patients to be aware of these prognostic factors to assist in providing comprehensive care, educating families, and understanding the treatment implications based on these factors. Understanding these nuances helps nurses in advocating for their young patients and supporting families through the complexities of cancer treatment.